Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytosorbents Corp CTSO

Healthcare Medical Devices
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive... see more

Recent & Breaking News (NDAQ:CTSO)

CytoSorbents Expands Distribution of CytoSorb® to Vietnam

PR Newswire December 15, 2015

CytoSorbents to Ring Opening Bell to Celebrate One Year NASDAQ Anniversary

PR Newswire December 9, 2015

CytoSorbents to Participate in Upcoming Investor Conferences

PR Newswire December 1, 2015

Moving Ahead of Averages, Technical Review - Research on Veritex Holdings, Lifeway Foods, Cytosorbents and NL Industries

Accesswire November 30, 2015

What Does the Data Say - Research on Ardmore Shipping, Cytosorbents, Elizabeth Arden and Xcerra

Accesswire November 20, 2015

CytoSorbents Accelerates Growth in Q3 2015

PR Newswire November 13, 2015

CytoSorbents To Meet With Investors at Brean Capital Life Sciences Summit and Stifel 2015 Healthcare Conference

PR Newswire November 9, 2015

CytoSorbents to Report Q3 2015 Operating and Financial Results

PR Newswire November 6, 2015

CytoSorbents To Advance HemoDefend(TM) Towards Commercialization with $1.5 Million Phase II SBIR Contract from NHLBI/NIH

PR Newswire October 27, 2015

CytoSorbents Reports CytoSorb® Usage Grows to 8,000+ Human Treatments at Successful Second International Users Meeting

PR Newswire October 5, 2015

CytoSorbents Ready for Second International CytoSorb® Users Meeting, ESICM and EACTS Conferences

PR Newswire September 30, 2015

World Sepsis Day 2015: CytoSorbents Sponsors the SepsisUpdate 2015 Congress, Hugo Schottmuller Prize, and Sepsis Heroes Ceremony

PR Newswire September 14, 2015

CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference

PR Newswire September 2, 2015

CytoSorbents Reports Steady Growth in Q2 2015

PR Newswire August 13, 2015

Saudi Food and Drug Authority Approves CytoSorb®

PR Newswire August 10, 2015

CytoSorbents to Report Q2 2015 Operating and Financial Results

PR Newswire August 6, 2015

CytoSorbents and TekMed Collaborate to Distribute CytoSorb® in Australia and New Zealand

PR Newswire July 23, 2015

Veteran Healthcare Analyst Michael G. Bator Joins CytoSorbents Board of Directors

PR Newswire July 15, 2015

CytoSorbents Corporation set to join Russell Microcap Index

PR Newswire June 19, 2015

CytoSorbents to Present at the LD Micro Invitational on June 1st

PR Newswire May 26, 2015